Bio-Modeling Systems: The Mechanisms-Based Mecidicine Company
  • 2018: POSITION PAPER : Paris November 5, 2018: Why Human Augmented Intelligence, the other AI, can "cure" the "Pharma chronic"too high failure rate" syndrome

  • 2018: ANNOUNCEMENT: BMSystems invited to present its CADI Discovery platform and achievements at 4 events in Europe,BioFit,-BioWin-Day,COST EC cluster conference, DGA BtoB  

  • 2018: PRESSE-RELEASE: L’Association Française du Syndrome de Fatigue Chronique (AFSC) change les règles du jeu et s’associe à Bio-Modeling Systems pour développer et valider un modèle explicatif et thérapeutique de l'EM/SFC (CFS/ME).

  • 2018: PRESS-RELEASE: Paris October 10, 2108: Bio-Modeling Systems, with its operational CADI™ Discovery platform, is the Integrative Biology partner of GEMMA (autism & microbiota) project selected for €14.2M H2020 funding by the European Commission to identify potential targets for the personalized treatment and prevention of Autism Spectrum Disorderss

  • 2018: PRESS-RELEASE: Paris 10 Octobre 2108: Bio-Modeling Systems, avec sa plateforme opérationnelle CADI™ Discovery est le partenaire « Biologie Intégrative » du  programme GEMMA (autisme & microbiote) sélectionné par la Commission européenne pour un financement H2020 de 14,2 millions d'euros afin d'identifier des cibles potentielles pour le traitement personnalisé et la prévention des troubles du spectre autistique

  • 2018: ANNOUNCEMENT: Paris September 4, 2018: How CADI Discovery, invented in 2004,  successfully addressed the "Garbage in Garbage out" Law of every Data Processing explained in Current Opinion in Pharmacology:  How scientific literature analysis yields innovative therapeutic hypothesis through integrative iterations.
     
  • 2018: PRESS-RELEASE: Paris  July17, 2018: World's first: The French Chronic Fatigue Syndrome Association decides to clinically evaluate the ME/CFS pathogenesis model produced by Bio-Modeling System.s

  • 2018: ANNOUNCEMENT: Paris June 19-20, 2018: BMSystems invited to the Microbiotes conference organized by Adebiotech to present its microbiota vision and CADI Discovery programs. 

  • 2018: ANNOUNCEMENT: Paris June 14, 2018: BMSystems invited to the Connected Health Conference organized by ANRT to present its Real life data strategy with its "patients & HCP digital pathways" partner Bolero.

  • 2018: ANNOUNCEMENT: Paris March 13-14, 2018: BMSystems invited to the Epigentic conference organised by Adebiotech to present its CADI Discovery program EPIGEN-DIAB with the Centrer of excelllence in Epigenetic in India.
Bio-Modeling Systems: The Mechanisms-Based Mecidicine Companys

BMSystems founders

- Dr. François Iris (PhD) : Chairman, Chief Science & Technology Officer

  • Geneticist, physiologist & molecular biologist. Creator of Millennium Pharmaceuticals' (USA) high-throughput DNA sequencing unit. Former collaborator of Nobel Laureate Prof. Jean Dausset. Inventor of new technologies in molecular biology.
  • International expert in Systems Biology / integrative Biology.
  • MRC Overseas fellow, Member of H.U.G.O., Wellcome Trust Systems Biology experts board. Member of the Cambridge Healthtech Institute Scientific Committee, Member of the Evaluation committee for the funding priorities in the "Medical Systems Biology- MedSys" program, German Federal ministry of Research.
  • 14 original articles in international journals including Nature, Cell, Nature Genetics, Genomics, J Mol Endocrinol, j Comp Biochem Physiol. 7 international patents, 1 patent application currently undergoing examination, 6 book chapters, numerous invited communications at international conferences.

- Manuel Gea: C.E.O & VP R& D Information Systems

  • Scientific Engineering Degree from Ecole Centrale Paris, Chairman of the Supervisory board of Pherecydes Pharma (anti-bacterial bio-agents pharmaceutical company) Former CEO Hemispherx Biopharma Europe. Founder and President of Centrale-Santé. Founding-Administrator of the computing firm Formitel. Former McKinsey executive, creator of Practice Pharma services in France. Former Division Managing Director with Boehringer-Ingelheim France. Former International business manager Colgate-Palmolive Company (US),
  • Co-founder and Vice President of the Biotech Committee of the Association of the Pharma companies operating France (LEEM). Member of the executive board and the R&D committee of Medicen Santé, the World class bio-cluster of Paris region.
  • Vice-President Adebiotech Committee. Co-founder and Evaluation Committee member of Paris Biotech (leading biotech incubator).

- Dr. Gérard Dine (MD, PhD): Chief Medical Officer.

  • Physician. Head of the Haematology Dept. at Troye's hospital. Founding member and Head of the Biotechnology Dept. at Ecole Centrale Paris.
  • Founding-President of Troye's Institute of Biotechnologies. Former President of the Institute for Sports Medicine.

- Paul-Henri Lampe: Bioinformatics & Systems Integration Director.

  • Systems Engineering & Systems Integration specialist. Scientific Engineering Degree from Ecole Centrale Lille. Master Degree in Applied Mathematics from Ecole Centrale Paris.
  • Former IBM Systems Integration Manager. Information Systems projects manager in an Acute Care Hospital in Paris.

- Pablo Santamaria: I.T. & On-line Information Systems Director

  • Scientific Degree from Ecole Centrale Paris, Founder and President of the computing firm Formitel (1988) .
  • Founding President of the Centrale-Ethics Think-Tank. Vice-President of Centrale Human Resources Professional group. Former Senior Consultant Information Systems Evaluation (INSEP). Former Industrial Maintenance Manager at Glaxo Pharma (Evreux, France)
Bio-Modeling Systems: a leading Integrative Heuristic Systems Biology / Predictive Integrative Biology Mechanisms-Based Medicine company that delivers